Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Xiuzheng Pharmaceutical Group Aims For A-Share Listing

This article was originally published in PharmAsia News

Executive Summary

Xiuzheng Pharmaceutical Group plans to go for A-share listing at the end of this year or early 2009, according to the company's president. As a TCM enterprise, Xiuzheng ranks among China's top 10 pharmaceutical corporations with its revenue of 5.7 billion yuan in 2007. The company will begin constructing its biomedical industry park with 1 billion yuan. With the biomedical industry its second largest core business, it aims to create value in the capital market for investors. An analyst notes that going public is inevitable for Xiuzheng, but whether it is the right move at a time when China's stock market is slowing down remains to be seen. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts